Concepts (237)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 16 | 2021 | 188 | 3.040 |
Why?
|
| Robotic Surgical Procedures | 5 | 2021 | 34 | 2.710 |
Why?
|
| Ureter | 9 | 2020 | 29 | 2.320 |
Why?
|
| Prostatic Neoplasms | 6 | 2021 | 109 | 2.220 |
Why?
|
| Ureteral Calculi | 4 | 2023 | 6 | 1.830 |
Why?
|
| Ureteral Obstruction | 4 | 2018 | 18 | 1.700 |
Why?
|
| Kidney Calculi | 4 | 2019 | 7 | 1.510 |
Why?
|
| Robotics | 5 | 2020 | 25 | 1.440 |
Why?
|
| Nephrectomy | 9 | 2012 | 39 | 1.390 |
Why?
|
| Ureteroscopy | 6 | 2021 | 8 | 1.300 |
Why?
|
| Kidney Pelvis | 3 | 2019 | 16 | 1.240 |
Why?
|
| Kidney Neoplasms | 8 | 2012 | 79 | 1.210 |
Why?
|
| Adipose Tissue | 2 | 2018 | 76 | 1.050 |
Why?
|
| Prostate | 2 | 2016 | 35 | 1.010 |
Why?
|
| Lithotripsy | 2 | 2019 | 3 | 0.970 |
Why?
|
| Humans | 46 | 2023 | 27307 | 0.890 |
Why?
|
| Prostatectomy | 3 | 2021 | 24 | 0.850 |
Why?
|
| Risk Assessment | 6 | 2019 | 631 | 0.810 |
Why?
|
| Kidney Diseases | 2 | 2016 | 72 | 0.800 |
Why?
|
| Carcinoma, Renal Cell | 4 | 2012 | 47 | 0.780 |
Why?
|
| Calculi | 2 | 2019 | 3 | 0.760 |
Why?
|
| Neoplasm Grading | 2 | 2018 | 55 | 0.660 |
Why?
|
| Intra-Abdominal Fat | 2 | 2018 | 40 | 0.650 |
Why?
|
| Endoscopy | 3 | 2019 | 182 | 0.640 |
Why?
|
| Male | 25 | 2023 | 14887 | 0.630 |
Why?
|
| Ureteral Diseases | 2 | 2016 | 3 | 0.620 |
Why?
|
| Staghorn Calculi | 1 | 2019 | 2 | 0.620 |
Why?
|
| Nephrotomy | 1 | 2019 | 2 | 0.620 |
Why?
|
| Urinary Diversion | 2 | 2017 | 3 | 0.610 |
Why?
|
| Cystectomy | 2 | 2017 | 8 | 0.610 |
Why?
|
| Creatinine | 1 | 2018 | 43 | 0.590 |
Why?
|
| Renal Artery | 2 | 2017 | 8 | 0.590 |
Why?
|
| Nephrolithotomy, Percutaneous | 1 | 2018 | 1 | 0.580 |
Why?
|
| Solitary Kidney | 1 | 2018 | 1 | 0.580 |
Why?
|
| Urinary Tract Infections | 2 | 2016 | 33 | 0.580 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2023 | 667 | 0.580 |
Why?
|
| Aorta, Abdominal | 1 | 2017 | 3 | 0.570 |
Why?
|
| Postoperative Complications | 4 | 2017 | 930 | 0.570 |
Why?
|
| Vascular Malformations | 1 | 2017 | 5 | 0.570 |
Why?
|
| Hydronephrosis | 3 | 2018 | 6 | 0.550 |
Why?
|
| Urinary Bladder | 2 | 2017 | 18 | 0.550 |
Why?
|
| Replantation | 2 | 2020 | 10 | 0.540 |
Why?
|
| Ileum | 1 | 2017 | 14 | 0.540 |
Why?
|
| Urinary Retention | 1 | 2017 | 13 | 0.540 |
Why?
|
| Retrospective Studies | 10 | 2023 | 3551 | 0.540 |
Why?
|
| Middle Aged | 14 | 2021 | 9068 | 0.520 |
Why?
|
| Candidiasis | 1 | 2016 | 28 | 0.510 |
Why?
|
| Body Mass Index | 3 | 2016 | 462 | 0.500 |
Why?
|
| Kidney Transplantation | 1 | 2017 | 119 | 0.500 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 95 | 0.490 |
Why?
|
| Aged | 14 | 2021 | 9120 | 0.470 |
Why?
|
| Nephrostomy, Percutaneous | 3 | 2016 | 5 | 0.430 |
Why?
|
| Kidney Medulla | 1 | 2013 | 1 | 0.410 |
Why?
|
| Nephrolithiasis | 1 | 2013 | 1 | 0.410 |
Why?
|
| Image-Guided Biopsy | 3 | 2018 | 37 | 0.400 |
Why?
|
| Calcinosis | 1 | 2013 | 44 | 0.400 |
Why?
|
| Female | 20 | 2018 | 15334 | 0.380 |
Why?
|
| Free Tissue Flaps | 1 | 2011 | 15 | 0.360 |
Why?
|
| Colic | 1 | 2009 | 1 | 0.330 |
Why?
|
| Minimally Invasive Surgical Procedures | 3 | 2019 | 316 | 0.330 |
Why?
|
| Adult | 9 | 2018 | 7945 | 0.320 |
Why?
|
| Pregnancy Complications | 1 | 2009 | 48 | 0.310 |
Why?
|
| Posture | 2 | 2008 | 63 | 0.310 |
Why?
|
| Rhabdomyolysis | 1 | 2008 | 5 | 0.290 |
Why?
|
| Awards and Prizes | 1 | 2008 | 22 | 0.290 |
Why?
|
| Liver Cirrhosis | 1 | 2008 | 44 | 0.290 |
Why?
|
| Cryosurgery | 4 | 2009 | 21 | 0.280 |
Why?
|
| Vas Deferens | 1 | 2007 | 1 | 0.280 |
Why?
|
| Granuloma | 1 | 2007 | 14 | 0.280 |
Why?
|
| Genital Diseases, Male | 1 | 2007 | 8 | 0.270 |
Why?
|
| Skin | 1 | 2008 | 130 | 0.270 |
Why?
|
| Sex Characteristics | 1 | 2008 | 118 | 0.270 |
Why?
|
| Spermatic Cord | 1 | 2007 | 17 | 0.270 |
Why?
|
| Treatment Outcome | 9 | 2019 | 3540 | 0.270 |
Why?
|
| Stents | 3 | 2017 | 81 | 0.260 |
Why?
|
| Sepsis | 1 | 2008 | 115 | 0.260 |
Why?
|
| Ultrasonography, Interventional | 2 | 2018 | 71 | 0.260 |
Why?
|
| Risk Factors | 5 | 2021 | 2335 | 0.260 |
Why?
|
| Ureteroscopes | 2 | 2021 | 2 | 0.250 |
Why?
|
| Incidence | 3 | 2017 | 763 | 0.240 |
Why?
|
| Neoplasm Staging | 5 | 2021 | 368 | 0.230 |
Why?
|
| Sutures | 3 | 2010 | 54 | 0.230 |
Why?
|
| Erectile Dysfunction | 2 | 2021 | 58 | 0.220 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2023 | 2 | 0.220 |
Why?
|
| Computers | 1 | 2023 | 17 | 0.200 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2017 | 33 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 1108 | 0.200 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 35 | 0.190 |
Why?
|
| Genomics | 1 | 2021 | 68 | 0.180 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 125 | 0.170 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 143 | 0.170 |
Why?
|
| Regression Analysis | 2 | 2018 | 258 | 0.170 |
Why?
|
| Electrosurgery | 2 | 2009 | 5 | 0.150 |
Why?
|
| Color | 1 | 2018 | 7 | 0.150 |
Why?
|
| Patient Positioning | 1 | 2019 | 38 | 0.150 |
Why?
|
| Monitoring, Intraoperative | 1 | 2019 | 37 | 0.150 |
Why?
|
| Pain, Postoperative | 2 | 2021 | 316 | 0.150 |
Why?
|
| Lymph Node Excision | 2 | 2017 | 27 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 165 | 0.150 |
Why?
|
| Margins of Excision | 1 | 2018 | 32 | 0.150 |
Why?
|
| Operative Time | 1 | 2019 | 92 | 0.150 |
Why?
|
| Tissue Adhesives | 2 | 2009 | 7 | 0.150 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 230 | 0.150 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 4841 | 0.140 |
Why?
|
| Feasibility Studies | 1 | 2018 | 214 | 0.140 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 1807 | 0.140 |
Why?
|
| Acute Disease | 1 | 2018 | 180 | 0.140 |
Why?
|
| Prostate-Specific Antigen | 1 | 2017 | 15 | 0.140 |
Why?
|
| Ultrasonic Therapy | 2 | 2008 | 24 | 0.140 |
Why?
|
| Pilot Projects | 1 | 2018 | 415 | 0.140 |
Why?
|
| Anastomosis, Surgical | 1 | 2017 | 29 | 0.130 |
Why?
|
| Endosonography | 1 | 2016 | 10 | 0.130 |
Why?
|
| Multimodal Imaging | 1 | 2016 | 28 | 0.130 |
Why?
|
| Contrast Media | 1 | 2016 | 64 | 0.130 |
Why?
|
| Postoperative Care | 1 | 2017 | 137 | 0.130 |
Why?
|
| Illinois | 1 | 2016 | 250 | 0.120 |
Why?
|
| Sus scrofa | 3 | 2010 | 7 | 0.120 |
Why?
|
| Patient Selection | 2 | 2007 | 197 | 0.120 |
Why?
|
| Clinical Competence | 2 | 2008 | 210 | 0.120 |
Why?
|
| Radiotherapy | 1 | 2015 | 33 | 0.120 |
Why?
|
| Hysterectomy | 1 | 2015 | 26 | 0.120 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2015 | 34 | 0.120 |
Why?
|
| Equipment Design | 5 | 2021 | 136 | 0.110 |
Why?
|
| Reoperation | 1 | 2019 | 921 | 0.110 |
Why?
|
| Vitamin D Deficiency | 1 | 2014 | 10 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2018 | 1903 | 0.110 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 306 | 0.110 |
Why?
|
| Vitamin D | 1 | 2014 | 37 | 0.110 |
Why?
|
| Pressure | 3 | 2008 | 65 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 270 | 0.100 |
Why?
|
| Models, Animal | 2 | 2010 | 111 | 0.100 |
Why?
|
| Hemostasis | 2 | 2011 | 11 | 0.100 |
Why?
|
| Animals | 9 | 2010 | 3681 | 0.100 |
Why?
|
| Urothelium | 1 | 2011 | 5 | 0.090 |
Why?
|
| Surgical Instruments | 2 | 2008 | 25 | 0.090 |
Why?
|
| Intraoperative Period | 1 | 2011 | 24 | 0.090 |
Why?
|
| Psoas Muscles | 1 | 2011 | 6 | 0.090 |
Why?
|
| Endometriosis | 1 | 2011 | 15 | 0.090 |
Why?
|
| Ureteral Neoplasms | 1 | 2011 | 7 | 0.090 |
Why?
|
| Iatrogenic Disease | 1 | 2011 | 25 | 0.090 |
Why?
|
| Swine | 5 | 2009 | 73 | 0.090 |
Why?
|
| Kidney | 2 | 2009 | 152 | 0.090 |
Why?
|
| Alloys | 2 | 2008 | 94 | 0.080 |
Why?
|
| Glutaral | 1 | 2010 | 2 | 0.080 |
Why?
|
| Serum Albumin, Bovine | 1 | 2010 | 5 | 0.080 |
Why?
|
| Wound Healing | 2 | 2009 | 159 | 0.080 |
Why?
|
| Length of Stay | 2 | 2008 | 321 | 0.080 |
Why?
|
| Adhesives | 1 | 2009 | 1 | 0.080 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2009 | 5 | 0.080 |
Why?
|
| Thoracic Duct | 1 | 2008 | 3 | 0.080 |
Why?
|
| Universities | 1 | 2009 | 40 | 0.080 |
Why?
|
| Lithotripsy, Laser | 1 | 2008 | 1 | 0.070 |
Why?
|
| Wounds and Injuries | 1 | 2009 | 46 | 0.070 |
Why?
|
| Pregnancy | 1 | 2009 | 339 | 0.070 |
Why?
|
| Teaching Materials | 1 | 2008 | 9 | 0.070 |
Why?
|
| Warm Ischemia | 1 | 2008 | 2 | 0.070 |
Why?
|
| Silicones | 1 | 2008 | 11 | 0.070 |
Why?
|
| Hematocrit | 1 | 2008 | 15 | 0.070 |
Why?
|
| Intestines | 1 | 2009 | 87 | 0.070 |
Why?
|
| Cystotomy | 1 | 2008 | 1 | 0.070 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2008 | 9 | 0.070 |
Why?
|
| Blood Loss, Surgical | 1 | 2008 | 56 | 0.070 |
Why?
|
| Vagina | 1 | 2008 | 38 | 0.070 |
Why?
|
| o-Phthalaldehyde | 1 | 2007 | 1 | 0.070 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2007 | 18 | 0.070 |
Why?
|
| Disinfectants | 1 | 2007 | 8 | 0.070 |
Why?
|
| Disinfection | 1 | 2007 | 11 | 0.070 |
Why?
|
| Urodynamics | 1 | 2007 | 3 | 0.070 |
Why?
|
| Retroperitoneal Space | 1 | 2007 | 8 | 0.070 |
Why?
|
| Hernia, Inguinal | 1 | 2007 | 21 | 0.070 |
Why?
|
| Time Factors | 2 | 2008 | 1444 | 0.070 |
Why?
|
| Colon | 1 | 2008 | 124 | 0.070 |
Why?
|
| Laser Therapy | 1 | 2006 | 11 | 0.060 |
Why?
|
| Recurrence | 1 | 2007 | 309 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 350 | 0.060 |
Why?
|
| Andropause | 1 | 2005 | 1 | 0.060 |
Why?
|
| Infertility, Male | 1 | 2005 | 6 | 0.060 |
Why?
|
| Catheter Ablation | 1 | 2006 | 62 | 0.060 |
Why?
|
| United States | 2 | 2021 | 2078 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2023 | 59 | 0.050 |
Why?
|
| Prognosis | 2 | 2021 | 808 | 0.050 |
Why?
|
| Immune System | 1 | 2021 | 15 | 0.050 |
Why?
|
| Seasons | 1 | 2021 | 22 | 0.040 |
Why?
|
| Search Engine | 1 | 2021 | 10 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2021 | 79 | 0.040 |
Why?
|
| Internet | 1 | 2021 | 91 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 170 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2010 | 261 | 0.040 |
Why?
|
| Swine, Miniature | 2 | 2009 | 6 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2011 | 675 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2014 | 35 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 276 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2007 | 1792 | 0.020 |
Why?
|
| Surveys and Questionnaires | 2 | 2008 | 1156 | 0.020 |
Why?
|
| Nephrons | 1 | 2011 | 6 | 0.020 |
Why?
|
| Electrodes | 1 | 2009 | 14 | 0.020 |
Why?
|
| California | 1 | 2009 | 36 | 0.020 |
Why?
|
| Temperature | 1 | 2009 | 62 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2008 | 23 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2008 | 28 | 0.020 |
Why?
|
| Equipment Safety | 1 | 2008 | 9 | 0.020 |
Why?
|
| Dissection | 1 | 2008 | 25 | 0.020 |
Why?
|
| Rabbits | 1 | 2009 | 180 | 0.020 |
Why?
|
| Holmium | 1 | 2008 | 1 | 0.020 |
Why?
|
| Laboratories | 1 | 2008 | 10 | 0.020 |
Why?
|
| Hemostasis, Surgical | 1 | 2008 | 15 | 0.020 |
Why?
|
| Device Removal | 1 | 2009 | 85 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2009 | 159 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2008 | 169 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2008 | 98 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2008 | 157 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 103 | 0.020 |
Why?
|
| Equipment Reuse | 1 | 2007 | 2 | 0.020 |
Why?
|
| Endoscopes | 1 | 2007 | 9 | 0.020 |
Why?
|
| Fiber Optic Technology | 1 | 2007 | 7 | 0.020 |
Why?
|
| Equipment Failure | 1 | 2007 | 39 | 0.020 |
Why?
|
| Equipment Contamination | 1 | 2007 | 26 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2007 | 67 | 0.020 |
Why?
|
| Peritoneum | 1 | 2007 | 16 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2007 | 93 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 375 | 0.020 |
Why?
|
| Pleural Diseases | 1 | 2007 | 2 | 0.020 |
Why?
|
| Punctures | 1 | 2007 | 11 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 486 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2007 | 83 | 0.020 |
Why?
|
| Models, Biological | 1 | 2009 | 320 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2007 | 46 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2008 | 643 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2007 | 109 | 0.020 |
Why?
|
| Probability | 1 | 2005 | 88 | 0.020 |
Why?
|
| Age Distribution | 1 | 2005 | 87 | 0.020 |
Why?
|
| Reference Values | 1 | 2005 | 185 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 2032 | 0.010 |
Why?
|
| Comorbidity | 1 | 2005 | 488 | 0.010 |
Why?
|
| Obesity | 1 | 2007 | 309 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2005 | 589 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 893 | 0.010 |
Why?
|